Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Sterility testing is an important part of GMP microbiology, and is used to ensure that pharmaceutical and biopharmaceutical therapeutics are sterile and safe for human use.
The global Pharmaceutical Sterility Testing market was valued at US$ 833.1 million in 2023 and is anticipated to reach US$ 1351.7 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Sterility Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Sterility Testing.
Report Scope
The Pharmaceutical Sterility Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Sterility Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Sterility Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Sterility Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Sterility Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sterility Testing
1.2.3 Bioburden Testing
1.2.4 Bacterial Endotoxin Testing
1.3 Market by Application
1.3.1 Global Pharmaceutical Sterility Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Compounding Pharmacies
1.3.3 Medical Devices Companies
1.3.4 Pharmaceutical Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Sterility Testing Market Perspective (2019-2030)
2.2 Pharmaceutical Sterility Testing Growth Trends by Region
2.2.1 Global Pharmaceutical Sterility Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical Sterility Testing Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical Sterility Testing Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical Sterility Testing Market Dynamics
2.3.1 Pharmaceutical Sterility Testing Industry Trends
2.3.2 Pharmaceutical Sterility Testing Market Drivers
2.3.3 Pharmaceutical Sterility Testing Market Challenges
2.3.4 Pharmaceutical Sterility Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Sterility Testing Players by Revenue
3.1.1 Global Top Pharmaceutical Sterility Testing Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical Sterility Testing Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Sterility Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Sterility Testing Revenue
3.4 Global Pharmaceutical Sterility Testing Market Concentration Ratio
3.4.1 Global Pharmaceutical Sterility Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Sterility Testing Revenue in 2023
3.5 Pharmaceutical Sterility Testing Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Sterility Testing Product Solution and Service
3.7 Date of Enter into Pharmaceutical Sterility Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Sterility Testing Breakdown Data by Type
4.1 Global Pharmaceutical Sterility Testing Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical Sterility Testing Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical Sterility Testing Breakdown Data by Application
5.1 Global Pharmaceutical Sterility Testing Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical Sterility Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Sterility Testing Market Size (2019-2030)
6.2 North America Pharmaceutical Sterility Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical Sterility Testing Market Size by Country (2019-2024)
6.4 North America Pharmaceutical Sterility Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Sterility Testing Market Size (2019-2030)
7.2 Europe Pharmaceutical Sterility Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical Sterility Testing Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical Sterility Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Sterility Testing Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical Sterility Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical Sterility Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical Sterility Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Sterility Testing Market Size (2019-2030)
9.2 Latin America Pharmaceutical Sterility Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical Sterility Testing Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical Sterility Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Sterility Testing Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical Sterility Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical Sterility Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical Sterility Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 SGS SA
11.1.1 SGS SA Company Detail
11.1.2 SGS SA Business Overview
11.1.3 SGS SA Pharmaceutical Sterility Testing Introduction
11.1.4 SGS SA Revenue in Pharmaceutical Sterility Testing Business (2019-2024)
11.1.5 SGS SA Recent Development
11.2 Toxikon, Inc.
11.2.1 Toxikon, Inc. Company Detail
11.2.2 Toxikon, Inc. Business Overview
11.2.3 Toxikon, Inc. Pharmaceutical Sterility Testing Introduction
11.2.4 Toxikon, Inc. Revenue in Pharmaceutical Sterility Testing Business (2019-2024)
11.2.5 Toxikon, Inc. Recent Development
11.3 Pace Analytical Services, LLC
11.3.1 Pace Analytical Services, LLC Company Detail
11.3.2 Pace Analytical Services, LLC Business Overview
11.3.3 Pace Analytical Services, LLC Pharmaceutical Sterility Testing Introduction
11.3.4 Pace Analytical Services, LLC Revenue in Pharmaceutical Sterility Testing Business (2019-2024)
11.3.5 Pace Analytical Services, LLC Recent Development
11.4 Boston Analytical
11.4.1 Boston Analytical Company Detail
11.4.2 Boston Analytical Business Overview
11.4.3 Boston Analytical Pharmaceutical Sterility Testing Introduction
11.4.4 Boston Analytical Revenue in Pharmaceutical Sterility Testing Business (2019-2024)
11.4.5 Boston Analytical Recent Development
11.5 Charles River Laboratories International, Inc.
11.5.1 Charles River Laboratories International, Inc. Company Detail
11.5.2 Charles River Laboratories International, Inc. Business Overview
11.5.3 Charles River Laboratories International, Inc. Pharmaceutical Sterility Testing Introduction
11.5.4 Charles River Laboratories International, Inc. Revenue in Pharmaceutical Sterility Testing Business (2019-2024)
11.5.5 Charles River Laboratories International, Inc. Recent Development
11.6 Nelson Laboratories.
11.6.1 Nelson Laboratories. Company Detail
11.6.2 Nelson Laboratories. Business Overview
11.6.3 Nelson Laboratories. Pharmaceutical Sterility Testing Introduction
11.6.4 Nelson Laboratories. Revenue in Pharmaceutical Sterility Testing Business (2019-2024)
11.6.5 Nelson Laboratories. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research